Literature DB >> 3266003

Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators.

C Sprik1, J D Wirtschafter.   

Abstract

Hemifacial spasm (HFS) due to intracranial mass lesions is rare. Most cases are thought to be due to compression of the facial nerve by small vessels near the root of the facial nerve. A survey was undertaken of all botulinum toxin investigators to determine the incidence of imaged mass lesions causing HFS. Responders contributed information on 1676 patients with HFS. Of this group, nine tumors were reported for an incidence of 0.54% of patients. However, of this group only 52.5% underwent computed tomography (CT) or magnetic resonance (MR) scanning so the incidence of tumor causing HFS could be as high as 1.0%. No one tumor type was predominant, and most patients were women older than 50 years of age. The incidence compares with another large series of HFS patients in which one tumor was found in 367 patients. The authors also report as an illustrative case a 26-year-old man with HFS due to a presumed lipoma of the cerebellopontine angle. This diagnosis can be made with increased certainty with MR scanning. If the incidence of unsuspected diagnostically significant mass lesions is 1 in 200 patients with HFS referred for botulinum toxin injection, the cost of detecting one such lesion would be $100,000 at an average imaging cost of $500 per MR imaging or CT examination. Although mass lesions are uncommon, any patient with HFS whose general clinical course could justify intervention should be considered for imaging studies to rule out treatable conditions other than vascular compression.

Entities:  

Mesh:

Year:  1988        PMID: 3266003     DOI: 10.1016/s0161-6420(88)33044-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Hemifacial spasm due to a large distant ipsilateral posterior fossa meningioma.

Authors:  G S Harrison; P Chovan; J H Lee
Journal:  Skull Base Surg       Date:  2000

2.  Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.

Authors:  Katja Kollewe; Bahram Mohammadi; Reinhard Dengler; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-05-01       Impact factor: 3.575

3.  Microsurgical treatment for 55 patients with hemifacial spasm due to cerebellopontine angle tumors.

Authors:  Hongyan Han; Guoqiang Chen; Huancong Zuo
Journal:  Neurosurg Rev       Date:  2010-03-09       Impact factor: 3.042

4.  A Case of Facial Spasm Associated with Ipsilateral Cerebellopontine Angle Arachnoid Cyst.

Authors:  Hiroshi Ogawa; Satoru Hiroshima; Kyousuke Kamada
Journal:  Surg J (N Y)       Date:  2015-09-16

5.  Magnetic resonance tomographic angiography in the investigation of hemifacial spasm.

Authors:  B Bernardi; R A Zimmerman; P J Savino; C Adler
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Management of symptomatic hemifacial spasm or trigeminal neuralgia.

Authors:  Ming-Xing Liu; Jun Zhong; Ning-Ning Dou; Lei Xia; Bin Li; Shi-Ting Li
Journal:  Neurosurg Rev       Date:  2016-02-15       Impact factor: 3.042

Review 7.  Botulinum toxin type A therapy for hemifacial spasm.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; P Moore; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Magnetic resonance imaging and angiography in hemifacial spasm.

Authors:  S Felber; G Birbamer; F Aichner; W Poewe; A Kampfl
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Hemifacial spasm as a manifestation of pilocytic astrocytoma in a pediatric patient.

Authors:  Marcelo R Masruha; Libânia M N Fialho; Marcel V da Nóbrega; Jaime Lin; Ricardo S Pinho; Sérgio Cavalheiro; Luiz Celso P Vilanova
Journal:  J Pediatr Neurosci       Date:  2011-01

10.  Botulinum toxin type A therapy for hemifacial spasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Mafalda Castelão; Raquel E Marques; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.